207 related articles for article (PubMed ID: 12805651)
1. Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation.
Tan YM; Butterworth BE; Gargas ML; Conolly RB
Toxicol Sci; 2003 Sep; 75(1):192-200. PubMed ID: 12805651
[TBL] [Abstract][Full Text] [Related]
2. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
3. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
[TBL] [Abstract][Full Text] [Related]
4. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice.
Constan AA; Sprankle CS; Peters JM; Kedderis GL; Everitt JI; Wong BA; Gonzalez FL; Butterworth BE
Toxicol Appl Pharmacol; 1999 Oct; 160(2):120-6. PubMed ID: 10527910
[TBL] [Abstract][Full Text] [Related]
6. Chloroform inhalation exposure conditions necessary to initiate liver toxicity in female B6C3F1 mice.
Constan AA; Wong BA; Everitt JI; Butterworth BE
Toxicol Sci; 2002 Apr; 66(2):201-8. PubMed ID: 11896286
[TBL] [Abstract][Full Text] [Related]
7. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938
[TBL] [Abstract][Full Text] [Related]
8. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
[TBL] [Abstract][Full Text] [Related]
9. Chloroform-induced cytolethality in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes.
Ammann P; Laethem CL; Kedderis GL
Toxicol Appl Pharmacol; 1998 Apr; 149(2):217-25. PubMed ID: 9571991
[TBL] [Abstract][Full Text] [Related]
10. The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride.
Delic JI; Lilly PD; MacDonald AJ; Loizou GD
Regul Toxicol Pharmacol; 2000 Oct; 32(2):144-55. PubMed ID: 11067771
[TBL] [Abstract][Full Text] [Related]
11. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs ad libitum in drinking water.
Larson JL; Wolf DC; Butterworth BE
Fundam Appl Toxicol; 1994 Jan; 22(1):90-102. PubMed ID: 8125218
[TBL] [Abstract][Full Text] [Related]
12. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
14. Nasal toxicity of chloroform in male F-344 rats and female B6C3F1 mice following a 1-week inhalation exposure.
Méry S; Larson JL; Butterworth BE; Wolf DC; Harden R; Morgan KT
Toxicol Appl Pharmacol; 1994 Apr; 125(2):214-27. PubMed ID: 7513449
[TBL] [Abstract][Full Text] [Related]
15. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice.
Sasso AF; Schlosser PM; Kedderis GL; Genter MB; Snawder JE; Li Z; Rieth S; Lipscomb JC
Toxicol Sci; 2013 Feb; 131(2):360-74. PubMed ID: 23143927
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
17. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice.
Butterworth BE; Templin MV; Constan AA; Sprankle CS; Wong BA; Pluta LJ; Everitt JI; Recio L
Environ Mol Mutagen; 1998; 31(3):248-56. PubMed ID: 9585263
[TBL] [Abstract][Full Text] [Related]
18. Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-response of tumor formation.
Templin MV; Constan AA; Wolf DC; Wong BA; Butterworth BE
Carcinogenesis; 1998 Jan; 19(1):187-93. PubMed ID: 9472711
[TBL] [Abstract][Full Text] [Related]
19. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
20. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
Bogen KT; Gold LS
Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
